Literature DB >> 12437928

CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion.

Anne Doye1, Amel Mettouchi, Guillaume Bossis, René Clément, Caroline Buisson-Touati, Gilles Flatau, Laurent Gagnoux, Marc Piechaczyk, Patrice Boquet, Emmanuel Lemichez.   

Abstract

CNF1 toxin is a virulence factor produced by uropathogenic Escherichia coli. Upon cell binding and introduction into the cytosol, CNF1 deamidates glutamine 63 of RhoA (or 61 of Rac and Cdc42), rendering constitutively active these GTPases. Unexpectedly, we measured in bladder cells a transient CNF1-induced activation of Rho GTPases, maximal for Rac. Deactivation of Rac correlated with the increased susceptibility of its deamidated form to ubiquitin/proteasome-mediated degradation. Sensitivity to ubiquitylation could be generalized to other permanent-activated forms of Rac and to its sustained activation by Dbl. Degradation of the toxin-activated Rac allowed both host cell motility and efficient cell invasion by uropathogenic bacteria. CNF1 toxicity thus results from a restricted activation of Rho GTPases through hijacking the host cell proteasomal machinery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12437928     DOI: 10.1016/s0092-8674(02)01132-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  110 in total

1.  Rac GTPase instructs nuclear factor-kappaB activation by conveying the SCF complex and IkBalpha to the ruffling membranes.

Authors:  Laurent Boyer; Sara Travaglione; Loredana Falzano; Nils C Gauthier; Michel R Popoff; Emmanuel Lemichez; Carla Fiorentini; Alessia Fabbri
Journal:  Mol Biol Cell       Date:  2003-12-10       Impact factor: 4.138

2.  Cytotoxic necrotizing factor 1 of Escherichia coli stimulates Rho/Rho-kinase-dependent myosin light-chain phosphorylation without inactivating myosin light-chain phosphatase in endothelial cells.

Authors:  Markus Essler; Stefan Linder; Barbara Schell; Katharina Hüfner; Agnès Wiedemann; Katharina Randhahn; James M Staddon; Martin Aepfelbacher
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

3.  Escherichia coli cytotoxic necrotizing factor 1 inhibits intestinal epithelial wound healing in vitro after mechanical injury.

Authors:  Patrick Brest; Laurent Turchi; Gaëlle Le'Negrate; Frédérick Berto; Chimène Moreilhon; Bernard Mari; Gilles Ponzio; Paul Hofman
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

4.  Ubiquitination: Added complexity in Ras and Rho family GTPase function.

Authors:  Michelle de la Vega; James F Burrows; James A Johnston
Journal:  Small GTPases       Date:  2011-07-01

5.  Ubiquitin proteasome pathway-mediated degradation of proteins: effects due to site-specific substrate deamidation.

Authors:  Edward J Dudek; Kirsten J Lampi; Jason A Lampi; Fu Shang; Jonathan King; Yongting Wang; Allen Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-30       Impact factor: 4.799

Review 6.  Invasion of Host Cells and Tissues by Uropathogenic Bacteria.

Authors:  Adam J Lewis; Amanda C Richards; Matthew A Mulvey
Journal:  Microbiol Spectr       Date:  2016-12

Review 7.  CNF1-like deamidase domains: common Lego bricks among cancer-promoting immunomodulatory bacterial virulence factors.

Authors:  Mengfei Ho; Amel Mettouchi; Brenda A Wilson; Emmanuel Lemichez
Journal:  Pathog Dis       Date:  2018-07-01       Impact factor: 3.166

Review 8.  Covert operations of uropathogenic Escherichia coli within the urinary tract.

Authors:  Jean M Bower; Danelle S Eto; Matthew A Mulvey
Journal:  Traffic       Date:  2005-01       Impact factor: 6.215

9.  TrkB-mediated activation of geranylgeranyltransferase I promotes dendritic morphogenesis.

Authors:  Xiu-Ping Zhou; Kong-Yan Wu; Bin Liang; Xiu-Qing Fu; Zhen-Ge Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-28       Impact factor: 11.205

10.  The small GTPase Rac is involved in clustering of hippocampal neurons and fasciculation of their neurites.

Authors:  J Leemhuis; U Mayer; H Barth; G Schmidt; D K Meyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-08-26       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.